News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Kang-Korea Alcohol Nominees Overwhelmingly Defeated at Dong-A Pharmaceutical (000640KS) EGM
October 31, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
SEOUL, South Korea--(BUSINESS WIRE)--Dong-A Pharmaceutical Co Ltd (000640 KS) announced today that all of the dissident Kang-Korea Alcohol nominees for election as director were overwhelmingly defeated at the October 31 EGM.
Twitter
LinkedIn
Facebook
Email
Print
Asia
MORE ON THIS TOPIC
Lung cancer
Kelun’s Merck-partnered ADC notches late-stage NSCLC win alongside Keytruda
July 15, 2026
·
2 min read
·
Michael Gibney
Deals
Spero bets up to $1.1B for Innovent’s autoimmune antibody
July 14, 2026
·
2 min read
·
Tristan Manalac
Lung cancer
AstraZeneca takes another China trip, picking Dizal’s lung cancer drug for up to $1.5B
July 14, 2026
·
2 min read
·
Tristan Manalac
Antibody-drug conjugates
GSK and Hansoh’s ADC clinches late-stage win, teeing up regulatory submission in China
July 10, 2026
·
1 min read
·
Gabrielle Masson